Papua New Guinea vs Seychelles: Opioid use disorder deaths by sex
Papua New Guinea
0.26 deaths
in 2021
Seychelles
0.19 deaths
in 2021
Papua New Guinea rank
141st
Seychelles rank
144th
Opioid use disorder deaths by sex over time
- Papua New Guinea
- Seychelles
How they compare
Papua New Guinea currently reports 0.26 deaths against 0.19 deaths in Seychelles, a difference of 0.07 deaths.
That makes Papua New Guinea's figure about 1.4 times Seychelles's.
Across all 22 years both countries report, Papua New Guinea has been ahead every year.
Papua New Guinea ranks 141st and Seychelles ranks 144th of 194 countries.
Papua New Guinea has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Papua New Guinea | Seychelles | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.225 deaths | 0.103 deaths | 0.122 deaths | Papua New Guinea |
| 2010s | 0.259 deaths | 0.145 deaths | 0.114 deaths | Papua New Guinea |
| 2020s | 0.26 deaths | 0.17 deaths | 0.09 deaths | Papua New Guinea |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher opioid use disorder deaths by sex, Papua New Guinea or Seychelles?
- Papua New Guinea, at 0.26 deaths against 0.19 deaths in Seychelles as of 2021.
- What is the difference in opioid use disorder deaths by sex between Papua New Guinea and Seychelles?
- 0.07 deaths, with Papua New Guinea ahead.
- How many years of comparable data are there for Papua New Guinea and Seychelles?
- 22 years are reported by both, from 2000 to 2021.
- How do Papua New Guinea and Seychelles rank globally for opioid use disorder deaths by sex?
- Papua New Guinea ranks 141st and Seychelles ranks 144th of 194 countries.
- Where does this data come from?
- World Health Organization (2024) β with major processing by Our World in Data, published as Opioid use disorder deaths by sex. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Estimated number of deaths from opioid use disorders in females.